Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Affimed N.V.
DescriptionTandAb antibody AFM21 combines a human antibody specifically binding to epidermal growth factor variant III (EGFRvIII) on the cell surface with an antibody recruiting immune effector cells
Molecular Target Epidermal growth factor variant III (EGFRvIII)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today